Clinical Trials Logo

Clinical Trial Summary

This is a prospective, observational, single-center, single-arm, clinical trial designed to assess the efficacy of FFRangio in measuring FFR obtained from angiography compared to Invasive FFR for diagnosing hemodynamically significant coronary stenosis in Multi-Vessel Disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03455244
Study type Observational
Source CathWorks Ltd.
Contact
Status Completed
Phase
Start date November 14, 2017
Completion date May 2, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02546557 - Optilene® Suture for Coronary Artery Bypass Graft Surgery
Recruiting NCT03424941 - The TransCatheter Valve and Vessels Trial N/A
Recruiting NCT03252990 - 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability
Recruiting NCT02325973 - Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI N/A
Not yet recruiting NCT01311323 - Revascularization in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) With Multivessel and/or Unprotected Left Main Coronary Disease N/A
Recruiting NCT03138473 - Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease
Recruiting NCT03479593 - Culprit Lesions in NSTEMI With Multi Vessel Disease (NSTEMI-CULPRIT)
Recruiting NCT03298659 - iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction N/A
Recruiting NCT02943954 - FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction N/A
Not yet recruiting NCT03700645 - Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Phase 4